HK1136969A1 - Product containing inactivated probiotic for infants - Google Patents

Product containing inactivated probiotic for infants

Info

Publication number
HK1136969A1
HK1136969A1 HK10104424.6A HK10104424A HK1136969A1 HK 1136969 A1 HK1136969 A1 HK 1136969A1 HK 10104424 A HK10104424 A HK 10104424A HK 1136969 A1 HK1136969 A1 HK 1136969A1
Authority
HK
Hong Kong
Prior art keywords
infants
product containing
containing inactivated
inactivated probiotic
infant
Prior art date
Application number
HK10104424.6A
Other languages
English (en)
Inventor
Udo Herz
Robert J Mcmahon
William Michael Russell
Josef Neu
Original Assignee
Mead Johnson Nutrition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39469924&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1136969(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mead Johnson Nutrition Co filed Critical Mead Johnson Nutrition Co
Publication of HK1136969A1 publication Critical patent/HK1136969A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK10104424.6A 2007-02-28 2010-05-05 Product containing inactivated probiotic for infants HK1136969A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90412207P 2007-02-28 2007-02-28
PCT/US2008/054717 WO2008106373A1 (en) 2007-02-28 2008-02-22 Product containing inactivated probiotic for children or infants

Publications (1)

Publication Number Publication Date
HK1136969A1 true HK1136969A1 (en) 2010-07-16

Family

ID=39469924

Family Applications (2)

Application Number Title Priority Date Filing Date
HK10104424.6A HK1136969A1 (en) 2007-02-28 2010-05-05 Product containing inactivated probiotic for infants
HK10108287.3A HK1141729A1 (zh) 2007-02-28 2010-09-01 用於治療或預防全身性炎症的方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK10108287.3A HK1141729A1 (zh) 2007-02-28 2010-09-01 用於治療或預防全身性炎症的方法

Country Status (14)

Country Link
US (2) US9408819B2 (xx)
EP (2) EP2114423B2 (xx)
CN (3) CN105796607A (xx)
AT (1) ATE544457T1 (xx)
BR (2) BRPI0808145A2 (xx)
CA (2) CA2676956C (xx)
ES (2) ES2388198T5 (xx)
HK (2) HK1136969A1 (xx)
MX (2) MX2009008875A (xx)
MY (2) MY151892A (xx)
PL (2) PL2114423T3 (xx)
RU (2) RU2468807C2 (xx)
TW (2) TWI494114B (xx)
WO (2) WO2008106372A1 (xx)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
PL2114423T3 (pl) * 2007-02-28 2012-10-31 Mjn Us Holdings Llc Produkt zawierający unieczynniony probiotyk dla niemowląt
WO2009071086A2 (en) * 2007-12-06 2009-06-11 Arla Foods Amba Probiotic bacteria and regulation of fat storage
RU2642301C9 (ru) * 2008-11-03 2018-06-27 Нестек С.А. Пробиотический бактериальный штамм для получения питательной композиции, улучшающей характер сна
EP3246039A1 (en) * 2009-04-29 2017-11-22 Ganeden Biotech, Inc. Bacterial cell membrane formulation
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
MY165388A (en) * 2009-05-11 2018-03-21 Nestec Sa Lactobacillus johnsonii la1 ncc533 (cncm i-1225) and immune disorders
EP2251022A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
WO2011090926A1 (en) * 2010-01-19 2011-07-28 Abbott Laboratories Nutritional formulas containing synbiotics
US9301982B2 (en) 2010-04-14 2016-04-05 Ganeden Biotech, Inc. Probiotic confection and lipid compositions
EP2452576A1 (en) * 2010-11-11 2012-05-16 Nestec S.A. Extruded non-replicating probiotic micro-organisms and their health benefits
EP2455092A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
EP2455093A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children
CN103209596A (zh) * 2010-11-11 2013-07-17 雀巢产品技术援助有限公司 含有益生微生物的冷冻糖食
EP2455094A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
US11235008B2 (en) 2011-03-31 2022-02-01 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
KR101166798B1 (ko) 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
WO2013103826A1 (en) * 2012-01-06 2013-07-11 Skyview Enterprise Ltd. Anti-inflammatory compounds in combination with hydrogen for the treatment of inflammation
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CA2920461C (en) * 2013-08-09 2023-01-03 Ab-Biotics, S.A. Probiotic for infantile excessive crying
CN105765058A (zh) * 2013-11-25 2016-07-13 雀巢产品技术援助有限公司 经热处理的乳酸双歧杆菌ncc2818制剂减轻变态反应的表现
CN118020922A (zh) * 2013-11-29 2024-05-14 雀巢产品有限公司 按年龄定制的具有不同蛋白质含量的营养组合物
ES2668934T3 (es) 2014-12-23 2018-05-23 4D Pharma Research Limited Polipéptido pirin y modulación inmune
JP6271093B1 (ja) 2014-12-23 2018-01-31 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 免疫調節
PE20180267A1 (es) 2015-06-15 2018-02-06 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
NZ777234A (en) 2015-06-15 2022-02-25 4D Pharma Res Ltd Compositions comprising bacterial strains
PE20180243A1 (es) 2015-06-15 2018-01-31 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
ES2662617T3 (es) 2015-11-20 2018-04-09 4D Pharma Research Limited Composiciones que comprenden cepas bacterianas
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
CN114712405A (zh) 2016-03-04 2022-07-08 4D制药有限公司 包含细菌菌株的组合物
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
ES2657665B1 (es) * 2016-09-05 2018-12-17 Pedro Jose DE LA FUENTE BLASCO Productos para la salud con probióticos inactivados y uso de dichos productos
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
CN107115362A (zh) * 2017-04-28 2017-09-01 青岛东海药业有限公司 凝结芽孢杆菌在制备预防或治疗支气管哮喘制剂中的应用
RS61872B1 (sr) 2017-05-22 2021-06-30 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
JP6978514B2 (ja) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
AU2018285445B2 (en) 2017-06-14 2020-03-26 Cj Bioscience, Inc. Compositions comprising bacterial strains
EP3600364B1 (en) 2017-06-14 2020-08-05 4D Pharma Research Limited Compositions comprising a bacterial strain of the genus megasphaera and uses thereof
HUE052319T2 (hu) 2017-06-14 2021-04-28 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
CN108041607A (zh) * 2017-12-26 2018-05-18 广州普正生物科技有限公司 一种护齿益生菌咀嚼软胶囊
RU2770463C1 (ru) * 2020-10-14 2022-04-18 федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный технический университет им. И.И. Ползунова" (АлтГТУ) Способ производства мягкого сыра
TWI802009B (zh) * 2021-09-16 2023-05-11 創百股份有限公司 使用熱致死的乳酸菌菌株來治療和/或預防微粒物質-誘發的肺損傷

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
US6156320A (en) * 1993-02-05 2000-12-05 Harry Parsekian Fermented milk nutraceuticals
RU2031586C1 (ru) * 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
US6180100B1 (en) * 1994-09-30 2001-01-30 Urex Biotech., Inc. Lactobacillus compositions and methods for treating urinary tract infections
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
EP0965643B1 (en) * 1998-06-17 2003-11-05 Societe Des Produits Nestle S.A. Mobile genetic elements as tools for genetic modification of L. delbrueckii or L. helveticus
US6399055B1 (en) * 1998-10-27 2002-06-04 Compagnie Gervais Danone Method and composition for treatment of infant diarrhea
IL143632A0 (en) * 1998-12-11 2002-04-21 Urex Biotech Inc Pharmaceutical compositions containing lactobacillus
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
WO2001058465A2 (en) * 2000-02-10 2001-08-16 Gregor Reid Probiotic therapy for newborns
MXPA03005465A (es) * 2000-12-18 2004-10-14 Probiohealth Llc Compuestos probioticos derivados de la cepa ke01 de lactobacillus casei.
KR100419132B1 (ko) * 2000-12-29 2004-02-18 조성근 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
ATE375164T1 (de) * 2001-02-06 2007-10-15 Nestle Sa Endotoxin-bindung durch milchsäurebakterien und bifidobacteria
US20030092163A1 (en) * 2001-07-26 2003-05-15 Collins John Kevin Probiotic bifidobacterium strains
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
PE20030274A1 (es) * 2001-07-26 2003-05-08 Alimentary Health Ltd Cepas de lactobacillus salivarius
EP1364586A1 (en) 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
US20050100531A1 (en) * 2002-06-13 2005-05-12 John Bienenstock Probiotic therapies
DK1565547T4 (da) * 2002-06-28 2013-01-14 Biosearch S A Probiotiske stammer, en fremgangsmåde til selektion deraf, præparater deraf samt anvendelse deraf
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
WO2004069156A2 (en) * 2003-01-30 2004-08-19 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
WO2004087178A1 (en) * 2003-03-31 2004-10-14 Alimentary Health Limited A formulation comprising a bacterial strain
PL1638415T3 (pl) 2003-06-23 2011-05-31 Nestec Sa Preparat dla niemowląt lub preparat pochodny
WO2005085287A1 (en) * 2004-03-03 2005-09-15 En-N-Tech, Inc. Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions
US20080255252A1 (en) * 2004-03-15 2008-10-16 Tissugen Pty. Ltd. Infectious Aetiology of Prostatic Disease and Methods to Identify Causative Agents
US8926952B2 (en) * 2005-04-08 2015-01-06 The Procter & Gamble Company Methods of use of probiotic bifidobacteria for human beauty benefits
EP1926395A1 (en) * 2005-04-13 2008-06-04 Nestec S.A. Infant formula with probiotics
US20060233762A1 (en) 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US20060233752A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
WO2006124630A2 (en) * 2005-05-13 2006-11-23 New England Medical Center Hospitals, Inc. Compositions and methods for enhancing the efficacy of vaccines
PL2114423T3 (pl) * 2007-02-28 2012-10-31 Mjn Us Holdings Llc Produkt zawierający unieczynniony probiotyk dla niemowląt

Also Published As

Publication number Publication date
US9408819B2 (en) 2016-08-09
WO2008106372A1 (en) 2008-09-04
RU2009135871A (ru) 2011-04-10
US20080206212A1 (en) 2008-08-28
CA2679374A1 (en) 2008-09-04
EP2124977B9 (en) 2012-05-02
CN101678053B (zh) 2015-12-16
ES2388198T3 (es) 2012-10-10
CN101678053A (zh) 2010-03-24
WO2008106373A1 (en) 2008-09-04
TWI418355B (zh) 2013-12-11
MX2009009119A (es) 2009-09-04
EP2124977A1 (en) 2009-12-02
HK1141729A1 (zh) 2010-11-19
RU2009135873A (ru) 2011-04-10
PL2114423T3 (pl) 2012-10-31
MY151892A (en) 2014-07-14
EP2114423B1 (en) 2012-06-06
BRPI0808052A2 (pt) 2014-06-24
CA2676956C (en) 2017-06-13
TW200900075A (en) 2009-01-01
US20080206213A1 (en) 2008-08-28
RU2468807C2 (ru) 2012-12-10
EP2114423A1 (en) 2009-11-11
CN101636172A (zh) 2010-01-27
EP2124977B1 (en) 2012-02-08
ES2381232T3 (es) 2012-05-24
ATE544457T1 (de) 2012-02-15
CN105796607A (zh) 2016-07-27
CA2679374C (en) 2016-05-31
BRPI0808145A2 (pt) 2021-03-23
CA2676956A1 (en) 2008-09-04
MX2009008875A (es) 2009-08-28
MY145769A (en) 2012-04-13
TW200906426A (en) 2009-02-16
EP2114423B2 (en) 2020-01-01
PL2124977T3 (pl) 2012-07-31
US9408818B2 (en) 2016-08-09
RU2468808C2 (ru) 2012-12-10
TWI494114B (zh) 2015-08-01
ES2388198T5 (es) 2020-07-14

Similar Documents

Publication Publication Date Title
HK1136969A1 (en) Product containing inactivated probiotic for infants
PH12014501749B1 (en) A nutritional composition comprising probiotics and improving sleep patterns
UA96984C2 (xx) ЗНИЖЕННЯ РИЗИКУ ДІАРЕЇ$РПаЎ±б
UA100985C2 (ru) Композиция для питания с нежизнеспособной бифидобактерией и неусваиваемым олигосахаридом
MY145116A (en) Infant or follow-on formula
MXPA04011664A (es) Probioticos y tolerancia oral.
MY159072A (en) Probiotics to increase iga secretion in infants born by caesarean section
MY197622A (en) Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
MX339112B (es) Formula alimenticia para bebes y niños pequeños que comprenden probioticos para bebes y niños pequeños.
MX2009009931A (es) Probioticos para reducir el desarrollo de alergia en lactantes nacidos por cesarea.
MY145410A (en) Method for preventing or treating respiratory infections and acute otitis media in infants
NZ613165A (en) Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated fatty acids and uses thereof
MY165628A (en) Human milk oligosaccharides for modulating inflammation
IN2012DN00878A (xx)
MY159076A (en) Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
DK1359816T3 (da) Kombination af probiotika
MX2020007198A (es) Composiciones que comprenden al menos un oligosacarido n-acetilado y al menos uno fucosilado para usar en la promocion de la capacidad digestiva en infantes y niños pequeños.
PT1782818E (pt) Composição farmacêutica que compreende bacillus coagulans e simeticone para o tratamento de patologias gastrointestinais
MXPA05006195A (es) Dispositivos para la denticion.
TH144912A (th) การลดความเสี่ยงในการเป็นโรคท้องเสีย
PH12017500873A1 (en) Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
RU2006122217A (ru) Способ предупреждения острых респираторных вирусных инфекций у детей дошкольного возраста
TH101435B (th) โภชนาการที่มีไบฟิโดแบคทีเรียมซึ่งไม่มีชีวิต และโอลิโกแซ็คคาไรด์ที่ย่อยไม่ได้
ES1059627Y (es) Maniqui bebe para la enseñanza y practica del masaje infantil.
AU315167S (en) Baby bottle bib